Table 1.
Groups | Sample | Age (years) | Sex | PMI | Neuropathological Diagnosis |
Proteomics | WB |
---|---|---|---|---|---|---|---|
Control | 1218 | 65 | F | 3 h 45 m | AD I/0 | + | - |
1277 | 74 | M | 9 h 25 m | AD I/0 | + | + | |
1368 | 45 | M | 18 h 30 m | AD 0/0 | + | + | |
1403 | 51 | F | 4 h | AD 0/0 | + | + | |
1438 | 67 | M | 5 h 50 m | AD I/0, Amyloid angiopathy | + | + | |
1563 | 59 | F | 5 h 30 m | AD I/0, Metastatic carcinoma | + | + | |
1576 | 60 | F | 12 h | AD I/0 | + | + | |
MixD | DM4 | 81 | F | 9 h 40 m | AD III/B, vascular encephalopaty | + | + |
DM5 | 89 | M | 11 h 30 m | AD III/A, vascular encephalopathy | + | + | |
DM6 | 85 | M | 12 h | AD V/B, vascular pathology | - | + | |
DM8 | 88 | F | 5 h | AD V/B, vascular pathology | + | + | |
DM1 | 83 | M | 2 h 30 m | AD VI/C, infarcts | + | + | |
DM3 | 76 | M | 6 h 30 m | AD VI/C, infarcts | + | + | |
DM7 | 81 | M | 15 h | AD VI/C, infarcts | + | + |